EVENT

5th International Update Meeting on Healing and Management of Chronic Wounds

Virtual ConferenceMarch 18 - 20, 2021

Ready to see the difference?

MolecuLight Headquarters

425 University Avenue
Suite 700
Toronto, ON M5G 1T6
Canada

US Address
MolecuLight Corp.
2403 Sidney Street,
Suite 286
Pittsburgh, PA 15203

T. +1 647-362-4684
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com

Sitemap

MolecuLight DX Device
MolecuLight i:X
MolecuLight i:X Case Studies
Publications
MolecuLight Posters
Clinical Image Gallery of Fluorescence Images

Reimbursement
Training Resources
Webcast Recordings
Wound Care VIDEO MASTER SERIES
MolecuLightDX Training Videos
User Documentation for the MolecuLight i:X
Frequently Asked Questions (FAQ)

MolecuLight Executive Team
MolecuLight Conferences & Events
MolecuLight Press Releases

Contact MolecuLight
Distributors
MolecuLight Careers

MolecuLight is SOC ll^®
Type l Accredited:

MolecuLight awarded
Premier’s Technology
Breakthrough Designation

MolecuLight i:X
is designated as a:

MolecuLight included
in ISWCAP Consensus
Guidelines:

MolecuLight is a proud
corporate member of:

Global

USA

©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.